Allosteric modulators: The new generation of receptor antagonist

被引：56

作者：

Kenakin, T ^{[1
]}

机构：

[1] GlaxoSmithKline Res & Dev, Assay Dev & Compound Profiling, Res Triangle Pk, NC 27709 USA

来源：

MOLECULAR INTERVENTIONS | 2004年 / 4卷 / 04期

关键词：

D O I：

10.1124/mi.4.4.6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Allosteric antagonists modulate the affinity and/or efficacy of agonists for receptors. Although the manner in which this modulation can occur can mimic that of simple competitive antagonists, allosteric antagonists possess unique properties that can present seemingly capricious profiles of antagonism. These unique properties also offer potentially useful patterns for therapeutic utility. This review summarizes methods to detect allosteric antagonism and some special properties of these receptor modulators.

引用

页码：222 / 229

页数：8

共 36 条

[21]

Kazmierski Wieslaw M., 2002, Current Drug Targets - Infectious Disorders, V2, P265, DOI 10.2174/1568005023342489

[22] Drug efficacy at G protein-coupled receptors [J].

Kenakin, T .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :349-379

[23] Efficacy at G-protein-coupled receptors [J].

Kenakin, T .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (02) :103-110

[24] Ivermectin:: A positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor [J].

Krause, RM ;

Buisson, B ;

Bertrand, S ;

Corringer, PJ ;

Galzi, JL ;

Changeux, JP ;

Bertrand, D .

MOLECULAR PHARMACOLOGY, 1998, 53 (02) :283-294

[25]

LAZARENO S, 1995, MOL PHARMACOL, V48, P362

[26] Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies [J].

Lazareno, S ;

Gharagozloo, P ;

Kuonen, D ;

Popham, A ;

Birdsall, NJM .

MOLECULAR PHARMACOLOGY, 1998, 53 (03) :573-589

[27]

Litschig S, 1999, MOL PHARMACOL, V55, P453

[28]

MAEDA K, IN PRESS J VIROL

[29] New approach to drug therapy in Alzheimer's dementia [J].

Maelicke, A ;

Albuquerque, EX .

DRUG DISCOVERY TODAY, 1996, 1 (02) :53-59

[30] Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease [J].

Maelicke, A ;

Schrattenholz, A ;

Samochocki, M ;

Radina, M ;

Albuquerque, EX .

BEHAVIOURAL BRAIN RESEARCH, 2000, 113 (1-2) :199-206

← 1 2 3 4 →